Skip to main content
logo
Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.65
-0.56 (-3.25%)
At close: Oct 30, 2026, 4:00 PM EDT
16.71
+0.06 (0.36%)
After-hours: Oct 30, 2026, 5:03 PM EDT

Aurinia Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
314.27287.25.75-78.02-108.18-180.97
Depreciation & Amortization
19.3619.4519.4511.652.712.76
Loss (Gain) From Sale of Investments
-8.48-10.18-12.73-12.14-1.570.66
Stock-Based Compensation
14.8314.6831.645.3132.331.24
Other Operating Activities
-156.31-166.71-5.125.352.0310.24
Change in Accounts Receivable
-16.69-4.91-12.46-10.611.93-15.42
Change in Inventory
1.07-6.460.48-15.87-9.07-5.64
Change in Accounts Payable
-1.07-1.870.861.24-0.794.08
Change in Unearned Revenue
0.723.675.793.763.05-
Change in Other Net Operating Assets
9.480.810.7815.86-1.93-4.65
Operating Cash Flow
177.16135.6644.39-33.46-79.53-157.69
Operating Cash Flow Growth
47.51%205.62%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.14-0.25-0.28-0.72-0.29-0.3
Sale (Purchase) of Intangibles
------1.2
Investment in Securities
-154.2-32.5239.595.88-59.68-84.53
Other Investing Activities
---0.04-11.86-0.66-17.84
Investing Cash Flow
-149.12-32.7739.26-6.71-60.63-103.87

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--13.14-11.99-10.03--
Net Debt Issued (Repaid)
-18.09-13.14-11.99-10.03--
Issuance of Common Stock
71.8814.959.277.173.47221.11
Repurchase of Common Stock
-108.88-107.92-46.37-2.28-1.04-
Financing Cash Flow
-55.09-106.11-49.09-5.132.43221.11

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-27.04-3.2234.56-45.3-137.73-40.45

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
177.03135.4144.11-34.18-79.82-158
Free Cash Flow Growth
47.96%206.99%----
Free Cash Flow Margin
55.02%47.84%18.76%-19.47%-59.55%-346.44%
Free Cash Flow Per Share
1.300.980.30-0.24-0.56-1.22
Levered Free Cash Flow
132.7391.4162.94-3.89-35.1-98.48
Unlevered Free Cash Flow
135.1594.1265.96-2.16-35.1-98.48

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
-2.822.180.51.980.26
Change in Working Capital
-6.5-8.785.45-5.61-6.82-21.63
SEC Filings: 10-K · 10-Q